EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis

Chun Li Yang, Xi Chen, Hui Jie Zhou, Wan Chun Wu, Li Qun Zou

Journal of Hematology · 2024-04 · 13 (1-2) · 46-51

DOI: 10.14740/jh1242 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Hematology, 2024-04. Verfasst von Chun Li Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HLHLAHSNK/T lymphomaPD-L1 antibodyTreatment

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Division of Radiotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Division of Medical Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Zitieren

APA

Yang, C. L., Chen, X., Zhou, H. J., Wu, W. C., & Zou, L. Q. (2024). Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis. Journal of Hematology, 13(1-2), 46-51. https://doi.org/10.14740/jh1242

Vancouver

Yang CL, Chen X, Zhou HJ, Wu WC, Zou LQ. Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis. Journal of Hematology. 2024;13(1-2):46-51. doi:10.14740/jh1242

BibTeX
@article{Yang2024,
  author = {Yang, Chun Li and Chen, Xi and Zhou, Hui Jie and Wu, Wan Chun and Zou, Li Qun},
  title = {Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis},
  journal = {Journal of Hematology},
  year = {2024},
  volume = {13},
  number = {1-2},
  pages = {46--51},
  doi = {10.14740/jh1242}
}
Kostenlos starten →